Area of research
Molecular Biology · Oncology
Research interest
Research interests include Prodrug, Chemistry, Bioorthogonal chemistry, Cancer cell, Proteasome, and Ubiquitin ligase.
Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs
Senolytic Prodrugs: A Promising Approach to Enhancing Senescence‐Targeting Intervention
Bioorthogonal PROTAC Prodrugs Enabled by On-Target Activation
Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery